Cartilage Destruction by Hemophilic Arthropathy Can Be Prevented by Inhibition of the Ferroptosis Pathway in Human Chondrocytes
Journal of Clinical Medicine · 18.01.2024 · 13 (2) · 559
DOI: 10.3390/jcm13020559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.01.2024. Verfasst von Nele Wagener und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Musculoskeletal Surgery, Charité-University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
Around 50% of hemophilia patients develop severe arthropathy, with even subclinical hemorrhage in childhood potentially leading to intra-articular iron deposition, synovia proliferation, neoangiogenesis, and eventual damage to articular cartilage and subchondral bone. Treatments typically include coagulation factor substitution, radiosynoviorthesis, and joint replacement for advanced cases. This study aims to elucidate programmed cell death mechanisms in hemophilic arthropathy (HA) to identify novel treatments. (2)
Methods
Human chondrocytes were exposed to lysed/non-lysed erythrocytes, ferroptosis inducer ML-162, cytokines (IL-1ß, TNFα), and ferric citrate, then assessed for metabolic activity, DNA content, and cell death using Alamar Blue, cyQUANT, and Sytox assays. Three-dimensional spheroids served as a cartilage model to study the effects of erythrocytes and ML-162. (3)
Results
Erythrocytes caused significant cell death in 2D cultures (p < 0.001) and damaged 3D chondrocyte spheroids. Iron citrate and erythrocytes reduced chondrocyte DNA content (p < 0.001). The ferroptosis pathway was implicated in cell death, with no effects from apoptosis and necroptosis inhibitors. (4)
Conclusions
This study offers insights into HA’s cell death pathway, suggesting ferroptosis inhibitors as potential therapies. Further studies are needed to evaluate their efficacy against the chronic effects of HA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Musculoskeletal Surgery, Charité-University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany.
ORCID-Profile: Nele Wagener, Sebastian Hardt, Matthias Pumberger, Friederike Schömig
Zitieren
APA
Wagener, N., Hardt, S., Pumberger, M., & Schömig, F. (2024). Cartilage Destruction by Hemophilic Arthropathy Can Be Prevented by Inhibition of the Ferroptosis Pathway in Human Chondrocytes. Journal of Clinical Medicine, 13(2), 559. https://doi.org/10.3390/jcm13020559
Vancouver
Wagener N, Hardt S, Pumberger M, Schömig F. Cartilage Destruction by Hemophilic Arthropathy Can Be Prevented by Inhibition of the Ferroptosis Pathway in Human Chondrocytes. Journal of Clinical Medicine. 2024;13(2):559. doi:10.3390/jcm13020559
BibTeX
@article{Wagener2024,
author = {Wagener, Nele and Hardt, Sebastian and Pumberger, Matthias and Schömig, Friederike},
title = {Cartilage Destruction by Hemophilic Arthropathy Can Be Prevented by Inhibition of the Ferroptosis Pathway in Human Chondrocytes},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {2},
pages = {559},
doi = {10.3390/jcm13020559}
}
EUVIMED